Login

$CLVT SEC Filings

Filed On Filing
12 Nov 2026 8-K: Other Events

LONDON, November 12, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offers (collectively,...

10 Nov 2026 8-K: Other Events

LONDON, November 10, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield with respect to the 2028 Notes and the 2028 Notes Total Consideration (as ...

04 Nov 2026 144
04 Nov 2026 8-K: Other Events

LONDON, November 4, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), has c...

03 Nov 2026 144
03 Nov 2026 10-Q
03 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

— Improved recurring organic revenue growth driven by portfolio transformation

13 Oct 2026 8-K/A: Completion of Acquisition or Disposition of Assets

On July 3, 2026, certain subsidiaries of Clarivate Plc (“Clarivate”) entered into a Stock and Asset Purchase Agreement (the “Purchase Agreement”) with an affiliate of Altaris, LLC (the “Buyer”), pursuant to which, among other things, Cla...

08 Oct 2026 Form 4: Levy Henry, President, LS&H

Gave up 263,576 shares to cover exercise price or tax ($387K)

06 Oct 2026 8-K: Completion of Acquisition or Disposition of Assets; Departure/Election of Directors or Officers; Compensation +1 more

Transaction sharpens strategic focus on leading Academia & Government and Intellectual Property segments

02 Oct 2026 Form 4: Cornick Kenneth L., Director

Received 17,215 shares as a grant or award ($28.7K) · Gave up 3,444 shares to cover exercise price or tax ($5.75K)

02 Oct 2026 Form 4: Bomba Jane L Okun, Director

Received 17,215 shares as a grant or award ($28.7K) · Gave up 181 shares to cover exercise price or tax ($302)

02 Oct 2026 Form 4: Snyder Andrew Miles, Director

Received 30,688 shares as a grant or award ($51.2K) · Gave up 1,012 shares to cover exercise price or tax ($1.69K)

24 Sep 2026 8-K: Other Events

LONDON, September 24, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash tender offer (the "Offer") ...

23 Sep 2026 8-K: Other Events

LONDON, September 23, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in c...

17 Sep 2026 8-K: Other Events

LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Corporation (the “Company”), has...

18 Aug 2026 Form 4: Lisowski Matthew J., Senior VP, CAO

Received 67,357 shares as a grant or award

18 Aug 2026 Form 4: Easton Michael M, Executive Vice President/CFO

Received 194,300 shares as a grant or award

17 Aug 2026 Form 4: Shem Tov Matitiahu S., Director

Gave up 47,633 shares to cover exercise price or tax ($93.4K)

14 Aug 2026 Form 3: Lisowski Matthew J., Senior VP, CAO

Holds 79,898 shares of Ordinary Shares

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support